About This Journal

Cancer, an international interdisciplinary journal of the American Cancer Society, publishes high-impact, peer-reviewed original articles and solicited content on the latest clinical research findings. Each issue of Cancer strives to be comprehensive, spanning the breadth of oncology disciplines and providing something for everyone involved in cancer research, risk reduction, treatment, and patient care.

The goal of Cancer is to publish research aligned with the American Cancer Society’s mission to save lives and move us closer to a world without cancer. Cancer is primarily interested in quality papers focused in the following research areas:

  • Risk reduction and early detection
  • Novel approaches to treatment
  • Large randomized clinical trial results
  • Understanding psychosocial aspects of care
  • Moving toward a tobacco-free society
  • Addressing and reducing health disparities

Are you ready to publish your research? Learn why you should consider Cancer as the home for your next paper.

 

Featured Content

Skip slideshow

Articles

Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population‐based assessment in seven million children

  •  3 October 2023

Abstract

Children with either overgrowth syndromes or features are at a significantly increased risk for childhood cancer. Results from this study may ultimately be used to guide recommendations for cancer surveillance in children with overgrowth syndromes/features and may also inform future research into cancer etiology.

Open access

What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network meta‐analysis

  •  3 October 2023

Abstract

Exercise, nutrition, and weight management guidelines are widely recognized; however, no recommendations have specifically focused on improving body composition in breast cancer patients. This review highlights the most effective interventions to improve body composition and assist in weight management for breast cancer patients during or following treatment.

More articles
free access

Index for rating diagnostic tests

  •  32-35
  •  1950
First page image
free access

The ever‐increasing importance of cancer as a leading cause of premature death worldwide

  •  3029-3030
  •  4 June 2021

Abstract

Cardiovascular disease and cancer are now the leading causes of premature death in the majority of countries worldwide, and cancer is likely to surpass cardiovascular disease as the leading causes of death at ages 30-70 in most countries over the course of this century. Governments must factor in these transitions in formulating and implementing their cancer and noncommunicable disease plans and tailor cost-effective measures to the local disease profile.

free access

Osteosarcoma incidence and survival rates from 1973 to 2004

  •  1531-1543
  •  5 February 2009

Abstract

This comprehensive, population-based description of osteosarcoma identified important differences in incidence, survival, pathologic subtype, and anatomic site among age groups and quantified the impact of osteosarcoma in Paget disease or as a second cancer on incidence and mortality rates. These findings may have implications for understanding the biology and epidemiology of osteosarcoma.

Open access

Annual report to the nation on the status of cancer, part 1: National cancer statistics

  • Cancer
  •  4251-4284
  •  27 October 2022

Abstract

The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate annually to provide updated information about cancer occurrence and trends in the United States. Part 1 of this year's report provides information on cancer incidence and mortality rates and trends for males and females and by race/ethnicity for common cancer sites, with an in-depth look at pancreatic cancer.

Open access

Risk of prostate cancer and death after benign transurethral resection of the prostate—A 20‐year population‐based analysis

  • Cancer
  •  3674-3680
  •  17 August 2022

Abstract

Men with low prostate-specific antigen (PSA) levels and a benign transurethral resection of the prostate can be reassured about their cancer risk and do not need to be monitored differently than any other men, but patients with high PSA levels should be considered for further follow-up. This study's findings add to a body of literature suggesting that normal histology from the prostate entails a low risk of death from the disease.

Open access

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

  • Cancer
  •  4423-4431
  •  28 July 2020

Abstract

The Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology developed clinical practice guidelines for the management of mucositis, with the first edition published in 2004 and periodically updated. This summary presents the 2019/2020 guidelines update, which is based on a systematic review, and generates a tool that will help clinicians to select evidence-based interventions.

Open access

The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types

  • Cancer
  •  3192-3201
  •  13 May 2020

Abstract

This review provides an overview of immuno-oncology therapies and those in development. It specifically focuses on bispecific T-cell engager (BiTE) technology, its mechanism of action, types of cancer in which it has had success, half-life-extended BiTE molecules, and their potential as an off-the-shelf, targeted immunotherapy.

free access

The ever‐increasing importance of cancer as a leading cause of premature death worldwide

  • Cancer
  •  3029-3030
  •  4 June 2021

Abstract

Cardiovascular disease and cancer are now the leading causes of premature death in the majority of countries worldwide, and cancer is likely to surpass cardiovascular disease as the leading causes of death at ages 30-70 in most countries over the course of this century. Governments must factor in these transitions in formulating and implementing their cancer and noncommunicable disease plans and tailor cost-effective measures to the local disease profile.

Recent issues

Latest news